Latest Biotech News

Ionis Pharmaceuticals achieved FDA approval for Dawnzera (donidalorsen), a prophylactic treatment for hereditary angioedema (HAE), marking its second rare disease approval within a year. The...

Cutting-edge AI technologies continue to revolutionize biotechnology, as exemplified by several breakthroughs. MIT researchers developed a generative AI model that proposed over 10 million novel...

Recent studies highlight critical advances in understanding and enhancing cancer immunotherapy. Research reveals that anti-PD-1 treatment significantly improves outcomes in gastric cancer patients...

Cutting-edge research has revealed novel molecular mechanisms driving cancer progression and potential therapeutic targets. Studies identify the GATOR1 complex as a potent tumor suppressor in...

The biopharmaceutical manufacturing landscape is undergoing profound transformation driven by artificial intelligence and digital technologies. Industry leaders like Sanofi demonstrate how...

Artificial intelligence and machine learning are making significant inroads across biotech research and healthcare delivery. OpenAI’s new model scored a gold medal at the International Math...

Novel neuroscience research challenges longstanding notions of brain plasticity and opens pathways to innovative therapies. Multiple studies show that the brain’s somatosensory body map remains...

Recent financial and strategic developments demonstrate continued investment and restructuring in the biotech sector. Calidi Biotherapeutics successfully closed a $6.9 million public offering to...

Researchers at the University of California San Diego have developed a novel graphene-mediated optical stimulation (GraMOS) technique that accelerates the maturation of human brain organoids. This...

Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), a prophylactic therapy for hereditary angioedema (HAE), marking the company's second recent approval for the rare disease....

Recent studies reveal pivotal molecular mechanisms influencing cancer progression and treatment resistance. A Nature Communications publication identified the GATOR1 complex as a tumor suppressor...

Addressing the challenge of protein engineering for human therapeutics, researchers have developed PROTEUS, a method that enables directed evolution of proteins within mammalian cells. Using the...

Scientists have discovered that hemoglobin within brain astrocytes functions as a powerful antioxidant defense, breaking down harmful hydrogen peroxide through a pseudoperoxidase activity. The...

Recent advances in quantum and photonic technologies mark significant progress for computing and imaging disciplines. Researchers at the University of Chicago engineered protein-based biological...

Industry leaders are harnessing artificial intelligence and digital transformations to optimize biologic drug development and manufacturing. Sanofi’s iLab initiative integrates AI, automation, and...

Groundbreaking research highlights novel immune and inflammatory pathways impacting disease progression. A new study shows the STING protein triggers ZBP1-dependent necroptosis independently of...

The biotechnology sector exhibits renewed vigor amid technological maturation and market shifts. Continuous biomanufacturing has achieved commercial readiness, delivering productivity gains and...

Emerging research offers promising new directions for neurological disease management. A Stanford Medicine study shows that epilepsy drugs targeting hyperactivity in the reticular thalamic nucleus...

Gilead Sciences has expanded into the in vivo cell therapy arena by acquiring Interius BioTherapeutics for $350 million. This acquisition grants Gilead a technology platform capable of genetically...

Ionis Pharmaceuticals secured FDA approval for Dawnzera (donidalorsen), a ligand-conjugated antisense therapy designed to prevent attacks in patients with hereditary angioedema (HAE). This marks...